Expression of androgen receptor and its regulatory molecule Lin28 in non-luminal subtype breast cancer

Androgen receptor (AR) was associated with favourable outcome in luminal breast cancer. However, the role of AR in non-luminal breast cancer remains inconclusive. The aim of the present study was to evaluate the clinical significance of the AR and its regulatory pathway in non-luminal subtypes of br...

Descripción completa

Detalles Bibliográficos
Autores principales: Sa-Nguanraksa, Doonyapat, Pongthong, Wanee, Samarnthai, Norasate, Mitpakdi, Kwanlada, Chuangsuwanich, Tuenjai, Limjindaporn, Thawornchai, Kulprom, Anchalee, O-Charoenrat, Pornchai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201307/
https://www.ncbi.nlm.nih.gov/pubmed/32382417
http://dx.doi.org/10.3892/mco.2020.2029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201307/
https://www.ncbi.nlm.nih.gov/pubmed/32382417
http://dx.doi.org/10.3892/mco.2020.2029

Ejemplares similares